Marilyn Jerome
Gynecology · Washington, DCNPI 1558415414
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $11,400 of the $13,578 with a category attached, or 84.0%. Astellas Pharma US Inc accounts for 88.2% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2023 at $6,829 and has fallen 85.4% since, to $1,000 in 2025.
Across 88 payments — averaging $154.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$12K
- AbbVie$240
- Pfizer$222
- Renovia Inc$161
- Myriad Women's Health, Inc.$156
- Astellas Pharma Global Development$118
- plus $701 from 23 others
What the payments were for
- Speaking & faculty fees$11,40084%
- Travel & lodging$1331%
- Food & beverage$2,02815%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 21 | $11,978 |
| AbbVie(2 entities) | 13 | $240 |
| Pfizer | 14 | $222 |
| Renovia Inc | 2 | $161 |
| Myriad Women's Health, Inc. | 1 | $156 |
| Astellas Pharma Global Development | 1 | $118 |
| Hologic Sales And Service, LLC | 2 | $90 |
| Millicent US Inc | 5 | $81 |
| Therapeuticsmd, Inc. | 3 | $53 |
| Coopersurgical, Inc. | 3 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Duchesnay USA Incorporated | 2 | $46 |
| Myovant Sciences Inc. | 2 | $43 |
| Aesculap, Inc. | 1 | $35 |
| Amgen | 2 | $34 |
| Exeltis, USA Inc. | 1 | $21 |
| Biogen | 1 | $19 |
| Merck | 1 | $19 |
| Teleflex LLC | 1 | $18 |
| Bayer | 1 | $17 |
| Aspira Women's Health Inc | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Organon | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Minerva Surgical, Inc | 1 | $13 |
| Avion Pharmaceuticals | 1 | $12 |
| Olympus America Inc. | 1 | $11 |
| Bolder Surgical LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$11,368
- myRisk$156
- Leva Pelvic Floor Trainer$107
How this compares
Too few gynecology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProliaDenosumab | 13 | $22,628 |
| Estradiol | 138 | $15,670 |
| PremarinEstrogens, Conjugated | 29 | $13,507 |
| YuvafemEstradiol | 43 | $9,259 |
| EstringEstradiol | 18 | $9,193 |
| Estradiol (Twice Weekly)Estradiol | 32 | $4,091 |
| ProgesteroneProgesterone, Micronized | 45 | $1,976 |
| Raloxifene Hcl | 24 | $1,713 |
| Estradiol (Once Weekly)Estradiol | 16 | $1,229 |
| Alendronate Sodium | 69 | $1,063 |
| ValacyclovirValacyclovir Hcl | 19 | $800 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin, Estring | $222 | $22,70047 claims |
| AmgenProlia | $34 | $22,62813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few gynecology providers in District of Columbiaon file to place this against a meaningful peer group, so we don't.
Other gynecology in Washington
- Gaby MoawadWashington$1.5M
- James SimonWashington$811K
- Anthony ScialliWashington$165K
- Andrew GoldsteinWashington$156K
- Erica DavenportWashington$13K
- Julian SafranWashington$6K
- Sharon MaloneWashington$3K
- Alyssa Small LayneWashington$3K
- Bandhana BajajWashington$2K
- George SammanWashington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.